GeoVax Labs Inc. (GOVXW)
0.12
-0.04 (-25.00%)
At close: Jan 15, 2025, 3:28 PM
0.12
-0.08%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | n/a |
| Market Cap | 19.16M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.49 |
| Volume | 1,333 |
| Avg. Volume (20D) | 0 |
| Open | 0.12 |
| Previous Close | 0.16 |
| Day's Range | 0.12 - 0.12 |
| 52-Week Range | 0.12 - 0.12 |
| Beta | undefined |
About GOVXW
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 17
Stock Exchange NASDAQ
Ticker Symbol GOVXW
Website https://www.geovax.com